Markets
President Trump Holds "Make America Wealthy Again Event" In White House Rose Garden
(Chip Somodevilla/Getty Images)
Eggs, obviously

Tariffs might be starting to show in America’s inflation rate — but where are prices rising the most?

Coffee. Content. Child care. What’s up (and down) as US inflation hits 2.7%?

Hyunsoo Rim
7/16/25 9:32AM

According to new data from the Bureau of Labor Statistics, consumer prices rose 2.7% year over year in June — slightly above forecast and the fastest pace since February — with some suggesting that President Trump’s sweeping tariffs may finally be filtering through to nudge up prices on a range of goods.

But beyond the monthly ups and downs, where has inflation hit hardest — and where have prices actually fallen — in the last 12 months?

Where are prices rising chart
Sherwood News

The bad news: Food at home is up 2.4% from last year, the fastest rate in nearly two years. Among the biggest contributors are eggs (up 27%) amid avian flu disruptions, while your morning coffee (up 13.4%) and evening steak (up 10.6%) have also gotten pricier on the back of squeezed supply and tariff jitters.

Electricity bills (up 5.8%) are another sore spot, partly due to AI-hungry data center demand straining outdated infrastructure. Elsewhere, in another sign that tariffs might be taking hold, import-heavy categories like kitchen and living room furniture (up 5.1%) are climbing fast.

The slightly-less-bad news: The cost of dining out is up 3.8% — still high, but easing from last month. Housing costs rose by the same amount, though that’s the slowest rate since November 2021. And tariff-sensitive categories like apparel and toys remain relatively flat from last year… for now.

The good news: While repairing a car has gotten pricier, fueling one hasn’t, with gasoline prices down 8.3% thanks to surging global oil supply. Meanwhile, it could be a good time to get globe-trotting: airfares are down 3.5% from June 2024 and hotel stays have fallen 3.7%, too.

For homebodies, maybe now’s the opportunity to invest in your favorite pastimes? TVs are 10.1% less expensive than they were — though what that means in reality, as we’ve discussed, is likely a little different — while sewing machines and supplies for the craftier-minded have plunged 17.4%. However, that may not last once new tariffs set in.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.